How to Get GLP-1 Online

Summary: Getting a GLP-1 online is now a five-step process: confirm your BMI or A1C qualifies, pick between manufacturer-direct, telehealth, or insurance, complete the medical intake, get the script reviewed, and arrange refrigerated shipping.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

You can get a GLP-1 prescription online in a single afternoon, but only if you walk in with the right information and pick the right path. In 2026 there are three legitimate routes: manufacturer-direct programs (LillyDirect for Zepbound, NovoCare for Wegovy and Ozempic), telehealth platforms (Ro, Hims, Henry Meds, Found, Mochi, Eden, others), and insurance-covered prescriptions through a primary care or endocrinology visit done by video. Each path has a different cost, a different paperwork load, and a different failure mode. This walks through all three.

A note before you start. The FDA declared the tirzepatide shortage resolved in late 2024 and semaglutide in early 2025 ^[3]. That decision narrowed the legal window for mass-market compounded copies. As of 2026 most compounded GLP-1s sold online are operating under personalized prescription exemptions or 503B facility carve-outs, and the FTC has been actively pursuing sellers that misrepresent compounded product as FDA-approved. Brand-name access has moved in the opposite direction: Lilly and Novo both run direct-to-consumer cash-pay programs that did not exist in 2023. The cheapest legitimate brand price right now usually beats most compounded retail prices.

Step 1: Confirm you actually qualify

Every legitimate online provider screens for the same FDA indication criteria. Knowing whether you meet them before you start saves an hour of wasted intake.

For weight loss the bar is one of:

• BMI of 30 or higher (obesity), or
• BMI of 27 or higher with at least one weight-related condition: hypertension, type 2 diabetes, high cholesterol, obstructive sleep apnea, cardiovascular disease, or non-alcoholic fatty liver disease ^[1][2].

For type 2 diabetes the bar is a documented diagnosis, typically supported by an A1C of 6.5% or higher or a fasting glucose of 126 mg/dL or higher on two readings.

There are hard contraindications that no honest provider will override. A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 is a stop sign on the boxed warning of both Wegovy and Zepbound ^[1][2]. Active pancreatitis, severe gastroparesis, and pregnancy are also exclusionary. If any of those apply, every online platform that prescribes responsibly will deny you, and you need to be talking to an in-person specialist about alternatives, not shopping for a more lenient telehealth service.

Step 2: Pick a path

The three routes are not interchangeable. Costs, medication options, and how much you fight for coverage differ across all three.

LillyDirect and NovoCare (manufacturer-direct)

LillyDirect is Eli Lilly's cash-pay storefront for Zepbound. You complete a short intake, get connected to an independent telehealth physician (currently fulfilled by FORM Health and other Lilly partners), and if approved the script ships in single-dose vials at $349 for 2.5 mg or $499 for 5 mg and above as of 2026 pricing ^[4]. KwikPens are also available at a higher price tier. The medication is FDA-approved Zepbound, not a compound.

NovoCare Pharmacy is the Novo Nordisk equivalent for Wegovy and Ozempic. Same model: complete intake, get reviewed by a telehealth clinician, receive shipment in Novo's standard multi-dose pen ^[5]. Wegovy through NovoCare runs around $349 a month for cash-pay patients at all doses as of 2026. Medicare and Medicaid enrollees are excluded from both programs.

These programs are the simplest path if you already know which brand you want and you can pay cash. No insurance fights, no compounded product question marks, no membership fees layered on top.

Telehealth (Ro, Hims, Henry Meds, Found, Mochi, Eden, others)

Telehealth platforms run the full intake, prescription, and shipping in-house. They use their own physician network, fulfill through partner pharmacies (sometimes brand, sometimes 503A or 503B compounding pharmacies for compounded semaglutide or tirzepatide), and bundle some combination of coaching, messaging, or refills into a monthly subscription.

The major players in 2026:

• Ro: Brand Wegovy and Zepbound via partner pharmacies, plus insurance navigation. Asynchronous intake, video if needed. No initial consult fee.
• Hims and Hers: Compounded oral kits and injectable options, brand fills where prescribed. Direct-to-consumer pricing transparency.
• Henry Meds: Compounded semaglutide and tirzepatide, no insurance, flat monthly pricing including consult and shipping.
• Found: Doctor-led weight loss program with prior-auth support for insurance and self-pay options.
• Mochi: Insurance-first model with prior authorization handled by their team.
• Eden: No membership fee, flat per-month brand pricing, doctor-led.
• Amazon One Medical: Bundles GLP-1 prescribing into the One Medical primary care subscription, fills through Amazon Pharmacy with Prime delivery.
• PlushCare: Lower-cost membership plus insurance billing.
• Walgreens Weight Management: $49 per visit, no subscription, brand GLP-1s starting at $149 a month.

Pick a telehealth platform when you want the process compressed into one app, when you want compounded options that the manufacturer-direct programs cannot offer, or when you want bundled coaching and messaging.

Insurance through your PCP or endocrinologist

If you have commercial insurance, the cheapest path is almost always through coverage. A Wegovy or Zepbound copay on a covered plan can be $25 to $100 a month versus $349 cash. The catch is that most plans require prior authorization, many require step therapy (proof that you tried phentermine, contrave, or a structured lifestyle program first), and an increasing number of plans exclude anti-obesity medications outright. A 2025 review found denial rates for GLP-1 prescriptions rose 25% between 2016 and 2023, with anti-obesity indications denied at roughly twice the rate of type 2 diabetes indications.

Your PCP or an endocrinologist can prescribe and submit the prior auth. Telehealth versions of this exist: PlushCare, Sesame, Amazon One Medical, and many state telehealth networks bill insurance the same way a physical clinic does. The visit format does not change what your plan covers.

Step 3: Complete the medical assessment

Whichever path you choose, the intake will ask for the same core data. Have it ready before you start and the visit takes ten minutes instead of forty-five.

What to have at hand:

• Current weight, height, and any weight trend over the past year.
• BMI (calculate it yourself ahead of time).
• A list of every prescription medication, including dose.
• Any prior weight loss interventions and outcomes (phentermine, bariatric surgery, prior GLP-1 trials).
• Recent labs if you have them: A1C, fasting glucose, lipid panel, comprehensive metabolic panel. Most telehealth platforms do not require labs to prescribe for weight loss, but having them speeds approval and is mandatory for diabetes indications.
• Personal and family history of thyroid cancer, MEN 2, pancreatitis, gallbladder disease, severe kidney disease.
• Pregnancy status and contraception plan for women of reproductive age (GLP-1s are contraindicated in pregnancy).
• Insurance card if you are billing insurance.
• A current photo of yourself in some platforms (used as a baseline and for identity verification).

The intake may be asynchronous (you submit and a clinician reviews on their schedule, usually 24 to 72 hours) or synchronous (live video or phone, scheduled within a few days). Asynchronous is faster on average. Synchronous is required by law in a small number of states, so the platform will route you accordingly.

A nurse practitioner can prescribe GLP-1s in most states. NPs have full prescriptive authority in 27 states plus DC, reduced or supervised authority in the rest. Telehealth platforms route your case to a clinician licensed in the state where you live, which is why the available providers shift when you change your shipping address.

Step 4: Prescription review and what to do if denied

If the clinician approves, the script is sent to the platform's partner pharmacy or to a pharmacy you specify (insurance route). If you are denied, here is the playbook.

Denial reason 1: You do not meet BMI or comorbidity criteria. The platform is following the FDA label. Trying a different platform that will approve you off-label is not a workaround, it is shopping for a prescriber who will write outside the indication, and you should not do it. The legitimate fallback is a lifestyle intervention plus targeted comorbidity treatment, or a different class of weight loss medication (phentermine-topiramate, naltrexone-bupropion, orforglipron oral once approved in your indication).

Denial reason 2: Contraindication. Personal or family history of MTC or MEN 2, active pancreatitis, severe gastroparesis, pregnancy. This is a stop sign. The fallback is in-person evaluation by an endocrinologist or obesity medicine specialist who can assess whether the contraindication actually applies and whether non-GLP-1 options fit.

Denial reason 3: Insurance prior authorization denied. This is the most common one. Your prescribing clinician submits a PA. The plan responds with a denial letter listing the criteria you failed. Read it. Common criteria:

• BMI not documented or not meeting threshold. Fix: get a weigh-in at a primary care office, send the chart note.
• Comorbidity not documented. Fix: lab results or a clinic note from the past 12 months showing the qualifying condition.
• Step therapy not met. Fix: pharmacy records of prior weight loss medication trials, or a structured lifestyle program completion letter.
• Off-label for the indication. Fix: switch the prescription to the FDA-approved drug for your indication (Wegovy or Zepbound for weight loss, not Ozempic or Mounjaro).

If the first PA is denied, file an appeal. Plans are required to provide a written appeal process, and many GLP-1 denials are overturned on appeal when the prescriber submits a more detailed letter of medical necessity. Telehealth platforms with insurance navigation teams (Found, Mochi, Ro) handle this for you. If you went through your PCP, the office's referral coordinator will run it.

If insurance is a permanent dead end, you can drop back to manufacturer-direct cash pay (LillyDirect, NovoCare) or to a telehealth platform with cash-pay brand or compounded pricing. The combined out-of-pocket math sometimes beats a high-deductible insurance copay anyway.

In-person fallback. If every online path denies you and you believe you qualify, see an obesity medicine specialist in person. The American Board of Obesity Medicine maintains a directory at abom.org. Specialists can document conditions a telehealth intake may not capture, run labs, write a more persuasive letter for insurance, and handle complex cases (history of bariatric surgery, complicated medication interactions, suspected secondary causes of obesity) that telehealth is not built for.

Step 5: Shipping and storage

Once approved and paid, the medication ships from the partner pharmacy. Refrigerated shipping is standard for both brand pens and compounded vials. Expect:

• Speed: Most platforms quote 3 to 7 business days. Some (Henry, Sprout, Eden) advertise 2 to 3 day shipping. Free shipping is standard on subscription platforms; pay-as-you-go fills may add $15 to $25.
• Cold chain: Pens and vials arrive in an insulated box with cold packs. Open and refrigerate immediately. Do not leave on the porch in summer.
• Storage: Unopened Wegovy and Zepbound pens are stable refrigerated until expiration. Once in use, Wegovy pens are good at room temperature for up to 28 days; Zepbound vials and pens have similar 21 to 28 day stability windows depending on form. Always check the label on your specific shipment for the beyond-use date the pharmacy printed ^[1][2].
• Lost or warm shipment: Call the dispensing pharmacy. Reputable platforms replace product damaged in transit. Do not inject medication that arrived warm or that you suspect was thermally compromised.

Spotting a legitimate provider versus a scam

The FTC has stepped up enforcement against fake GLP-1 sellers, and the FDA has issued warning letters to platforms shipping products without valid prescriptions. Red flags:

• "No prescription required" or "no doctor visit needed." All GLP-1 receptor agonists are prescription-only. Anyone advertising otherwise is operating outside US law.
• Prices below $100 a month for "tirzepatide" or "semaglutide". The raw API does not exist at that price point through any compliant supply chain.
• No US business address, no pharmacy license number, payment only by crypto or wire.
• Selling "research peptides" or "not for human consumption" labeled vials. Research-grade peptides are exempt from FDA review precisely because they are not approved or quality-tested for human use. The dosing on this site and clinical references does not apply.
• Sublingual drops, oral sprays, or transdermal "GLP-1 patches." None of these delivery routes are validated for semaglutide or tirzepatide. The FDA-approved oral version (Rybelsus, and now oral Wegovy) is a specifically formulated tablet, not a compounded sublingual.

Legitimate platforms display the prescribing clinician's state license, the partner pharmacy's name and license, and a clear path to contact a real human about your prescription. Cross-check the pharmacy through your state board of pharmacy lookup. Cross-check the clinician through the state medical board.

What the 2026 landscape actually looks like

Compounded GLP-1s narrowed in 2025 after the FDA declared semaglutide and tirzepatide shortages resolved ^[3]. Mass-market compounding ended; what remains is true personalized compounding (different strength, different excipient because of allergy, alternate dosing form) at 503A pharmacies, plus 503B facility output that meets the federal carve-out criteria. If a telehealth platform still offers compounded options at scale in 2026, ask exactly which pharmacy and under what FDA exemption. The legitimate answers exist; vague answers are a warning.

Brand-name access widened. LillyDirect and NovoCare did not have today's footprint two years ago. TrumpRx, launched in 2026, brokers federally-negotiated coupon pricing for Wegovy pills at around $149 a month and injectable Wegovy and Ozempic at around $199 a month for non-Medicare patients. Lilly's vial format brought Zepbound down to $349 to $499 cash, which was unthinkable when only the KwikPen existed.

Medicare and Medicaid coverage of GLP-1 anti-obesity medications remains limited. The CMS Medicare GLP-1 Bridge program, scheduled to begin July 2026, will offer eligible Part D beneficiaries access ahead of the BALANCE model rollout in January 2027. Until then, Medicare patients pay cash or qualify for manufacturer patient assistance (Lilly Cares and Novo Nordisk PAP), which can provide free medication for patients under 200% to 300% of the federal poverty level.

Frequently asked questions

Can I really get GLP-1 online without an in-person doctor visit?

Yes. Every major platform (LillyDirect, NovoCare, Ro, Hims, Henry, Found, Mochi, Amazon One Medical, Walgreens) prescribes via telehealth with no in-person visit required, as long as your state allows asynchronous or video-only prescribing for GLP-1s, which most do.

Who can prescribe GLP-1 online?

Any clinician with prescriptive authority in your state: MDs, DOs, NPs in full-practice states, and PAs under physician oversight. Telehealth platforms route your case to a licensed clinician in your state.

Can a nurse practitioner prescribe GLP-1?

Yes, in any state where NPs have prescriptive authority for non-controlled prescription medications. That covers all 50 states for GLP-1s, with some states requiring physician collaboration agreements.

How do I tell if a GLP-1 telehealth provider is legitimate?

Look for a visible state pharmacy license, a named partner pharmacy, a listed prescribing clinician with verifiable state license, US business address, and a requirement to complete a medical intake. Avoid any site that ships without a prescription or sells "research peptides."

Is compounded GLP-1 the same as brand-name?

No. Compounded versions are not FDA-reviewed for safety, potency, or sterility. Quality varies between compounding pharmacies. Brand Wegovy and Zepbound undergo FDA inspection of manufacturing facilities; compounded copies do not.

How fast can I get GLP-1 shipped?

Most telehealth platforms ship within 3 to 7 business days after approval. The fastest (Henry, Sprout, Eden) advertise 2 to 3 day delivery. Manufacturer-direct programs typically ship in 5 to 10 business days.

What if I have Medicare?

Medicare does not currently cover GLP-1s for weight loss. You can pay cash through LillyDirect or NovoCare (Medicare patients are excluded from TrumpRx coupons), or apply to Lilly Cares or Novo Nordisk PAP if you fall under the income threshold. The Medicare GLP-1 Bridge program begins July 2026.

How much does GLP-1 cost online without insurance?

Brand Wegovy through NovoCare runs around $349 a month. Brand Zepbound through LillyDirect runs $349 to $499 for vials. Telehealth platforms with compounded options range from $199 to $399 a month all-in. Subscription platforms with brand fills run $200 to $500 plus medication.

What is the prior authorization process for GLP-1 through insurance?

Your prescriber submits a PA form with documentation of BMI, comorbidities, and prior weight loss attempts. The plan approves, denies with criteria, or requests step therapy. If denied, file a written appeal with a letter of medical necessity. Telehealth platforms like Found, Mochi, and Ro handle the paperwork for you.

Can I switch from compounded to brand-name later?

Yes. Your prescriber writes a new script for the brand at the equivalent dose. You restart the cold chain at the brand pharmacy. There is no medical reason to taper between compounded and brand at the same milligram dose, but discuss with your prescriber.

Is there a wait list for online GLP-1?

Not generally in 2026. The 2024 to 2025 shortage that drove wait lists is over, and most platforms approve and ship within a week. Wait list language on a sales page is usually a marketing tactic.

Does any provider offer GLP-1 with no membership fee?

Yes. Eden, Walgreens Weight Management ($49 per visit), and Amazon Pharmacy (if you already have a script) bill per fill without a recurring subscription. Most other telehealth platforms charge monthly.

Bottom line

Three paths, one set of qualification rules, and a five-step flow that fits in a single week. If you can pay cash and you know which brand you want, LillyDirect or NovoCare is the cleanest route. If you want bundled coaching and a single app, a telehealth platform like Ro, Hims, Eden, Found, or Henry will get you there. If you have commercial insurance with anti-obesity coverage, your PCP or a video-based PCP service is the cheapest option, and prior authorization is winnable when you arrive with documented BMI and comorbidities. The in-person fallback is real and underused: an obesity medicine specialist can solve cases that no telehealth intake will.

The medication itself is the same molecule regardless of which path delivers it. What changes is the price, the paperwork, and how much support you get during titration. Pick on those three.